Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
-6.13%
OPERATING MARGIN AVG 15Y
-3.59%
OPERATING MARGIN AVG 20Y
-2.11%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
+100.00%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 644 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Enveric Biosciences, Inc.
Market Cap
$6.67M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.69M
Operating Margin
-9312.55%
TTM Avg
-10684.89%
3Y Avg
-9259.36%
5Y Avg
-8523.06%
Market Cap
$6.43M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.92M
Operating Margin
-450.07%
TTM Avg
-699.99%
3Y Avg
-986.00%
5Y Avg
-5433.17%
Market Cap
$7.00M
Operating Margin
-4200.46%
TTM Avg
-2747.44%
3Y Avg
-7258.72%
5Y Avg
-5806.97%
Market Cap
$7.00M
Operating Margin
-5025.53%
TTM Avg
-3024.64%
3Y Avg
-1688.76%
5Y Avg
-1108.68%
Market Cap
$6.27M
Operating Margin
-119.54%
TTM Avg
-108.09%
3Y Avg
-117.27%
5Y Avg
-99.55%
Market Cap
$7.13M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-19.45%
5Y Avg
-19.45%
Market Cap
$6.17M
Operating Margin
-763.90%
TTM Avg
-929.35%
3Y Avg
-1043.46%
5Y Avg
-924.75%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | $6.67M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aclarion, Inc. (ACON)vs › | $6.69M | -9312.55% | -10684.89% | -9259.36% | -8523.06% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.43M | 0.00% | 0.00% | 0.00% | 0.00% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.92M | -450.07% | -699.99% | -986.00% | -5433.17% |
| Mangoceuticals, Inc. (MGRX)vs › | $7.00M | -4200.46% | -2747.44% | -7258.72% | -5806.97% |
| Co-Diagnostics, Inc. (CODX)vs › | $7.00M | -5025.53% | -3024.64% | -1688.76% | -1108.68% |
| Biomerica, Inc. (BMRA)vs › | $6.27M | -119.54% | -108.09% | -117.27% | -99.55% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.13M | 0.00% | 0.00% | -19.45% | -19.45% |
| Femasys Inc. (FEMY)vs › | $6.17M | -763.90% | -929.35% | -1043.46% | -924.75% |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.22M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 6.49% |
| 2020-09-30 | -13.19% |
| 2020-06-30 | -14.37% |
| 2020-03-31 | -16.69% |
| 2019-12-31 | -21.90% |
| 2019-09-30 | -17.11% |
| 2019-06-30 | -13.40% |
| 2019-03-31 | -12.15% |
| 2018-12-31 | -105.03% |
| 2018-09-30 | 57.68% |
| 2018-06-30 | -8.53% |
| 2018-03-31 | -12.35% |
| 2017-12-31 | -33.93% |
| 2017-09-30 | -31.49% |
| 2017-06-30 | -28.60% |
| 2017-03-31 | -5.11% |
| 2016-12-31 | -17.52% |
| 2016-09-30 | -12.84% |
| 2016-06-30 | -14.01% |
| 2016-03-31 | -13.99% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | -1.50% |
| 2015-06-30 | 12.34% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 8.60% |
| 2007-09-30 | -196.72% |
| 2007-06-30 | 40.69% |
| 2007-03-31 | 64.23% |
| 2006-12-31 | -80.53% |
| 2006-09-30 | -90.40% |
| 2006-06-30 | -64.63% |
| 2006-03-31 | -173.36% |
| 2005-12-31 | -118.02% |
| 2005-09-30 | 12.62% |
| 2005-06-30 | 13.23% |
| 2005-03-31 | 2.51% |
| 2004-12-31 | 34.22% |
| 2004-09-30 | -39.64% |
| 2004-06-30 | -50.09% |
| 2004-03-31 | -71.56% |
| 2003-12-31 | -29.16% |
| 2003-09-30 | -30.10% |
| 2003-06-30 | -83.47% |
| 2003-03-31 | -21.39% |
| 2002-12-31 | -4.94% |
| 2002-09-30 | 2.31% |
